{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:46:32Z","timestamp":1772808392108,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1532\/ijh97.03156","type":"journal-article","created":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T13:52:32Z","timestamp":1192715552000},"page":"260-265","source":"Crossref","is-referenced-by-count":24,"title":["Epstein-Barr Virus-Associated Composite Lymphoma Composed of Peripheral T-Cell Lymphoma and an Anaplastic Variant of a Diffuse Large B-Cell Type of Non-Hodgkin's Lymphoma and Strongly Expressing p53 Protein"],"prefix":"10.1007","volume":"79","author":[{"given":"Yuko","family":"Hirose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Wano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/1097-0142(197709)40:3<959::AID-CNCR2820400302>3.0.CO;2-3","author":"Kim, H","year":"1977","unstructured":"Kim H, Hendrickson MR, Dorfman RF. Composite lymphoma. Cancer. 1977;40:959-976.","journal-title":"Cancer"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ajcp\/99.4.445","author":"Kim, H","year":"1993","unstructured":"Kim H. Composite lymphoma and related disorders. Am J Clin Pathol. 1993;99:445-451.","journal-title":"Am J Clin Pathol"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ajcp\/96.1.81","author":"Gonzalez, CL","year":"1991","unstructured":"Gonzalez CL, Meroides LJ, Jaffe ES. Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin's disease and non-Hodgkin's lymphoma. Am J Clin Pathol. 1991;96:81-89.","journal-title":"Am J Clin Pathol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0145-2126(91)90468-9","author":"Tobinai, K","year":"1991","unstructured":"Tobinai K, Ohtsu T, Hayashi M, et al. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. Leuk Res. 1991;15:837-846.","journal-title":"Leuk Res"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ajcp\/98.4.424","author":"Strickler, JG","year":"1992","unstructured":"Strickler JG, Amsden TW, Kurtin PJ. Small B-cell lymphoid neoplasms with coexisting T-cell lymphomas. Am J Clin Pathol. 1992; 98:424-429.","journal-title":"Am J Clin Pathol"},{"key":"E00006","first-page":"641","author":"Liu, YC","year":"1994","unstructured":"Liu YC, Tomashefski JF Jr, Cleveland RP, et al. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, and molecular genetic documentation of concurrent lymph node involvement. Mod Pathol. 1994;7:641-646.","journal-title":"Mod Pathol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","author":"Zettl, A","year":"2002","unstructured":"Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002;117:368-379.","journal-title":"Am J Clin Pathol"},{"key":"E00008","unstructured":"Delsol G, Ralfkiaer E, Stein H,Wright D, Jaffe ES.Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification:Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:230-235."},{"key":"E00009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.1711680212","author":"Borisch, B","year":"1992","unstructured":"Borisch B, Finke J, Hennig I, et al. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol. 1992;168: 229-236.","journal-title":"J Pathol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V82.2.619.619","author":"Hamilton-Dutroit, SJ","year":"1993","unstructured":"Hamilton-Dutroit SJ, Raphael M, Audouin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood. 1993;82:619-624.","journal-title":"Blood"},{"key":"E00011","first-page":"4253","author":"Hanto, DW","year":"1981","unstructured":"Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981;41:4253-4261.","journal-title":"Cancer Res"},{"key":"E00012","first-page":"736","author":"Penn, I","year":"1981","unstructured":"Penn I. Malignant lymphomas in organ transplant recipients. Transplant Proc. 1981;13:736-738.","journal-title":"Transplant Proc"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","author":"Kamel, OW","year":"1993","unstructured":"Kamel OW, van de Riin M, Weiss LM, et al. Brief report: reversible lymphoma associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328:1317-1321.","journal-title":"N Engl J Med"},{"key":"E00014","first-page":"47","author":"Dawson, TM","year":"2001","unstructured":"Dawson TM, Starkebaum G, Wood BL, Wilkins RF, Gown AM. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sj\u00f6gren's syndrome: case series. J Rheumatol. 2001;28:47-53.","journal-title":"J Rheumatol"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF02982134","volume":"75","author":"Hirose, Y","year":"2002","unstructured":"Hirose Y, Masaki Y, Okada J, et al. Epstein-Barr virus associated B-cell type non-Hodgkin's lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate. Int J Hematol. 2002;75:412-415.","journal-title":"Int J Hematol"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","volume":"74","author":"Anagnostopoulos, I","year":"1989","unstructured":"Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood. 1989;74:810-816.","journal-title":"Blood"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood.V78.10.2666.2666","volume":"78","author":"Herbst, H","year":"1991","unstructured":"Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas. Blood. 1991;78:2666-2673.","journal-title":"Blood"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0046-8177(97)90232-X","author":"Shimakage, M","year":"1997","unstructured":"Shimakage M, Nakamine H, Tamura S, Takenaka T, Yutsudo M, Hakura H. Detection of Epstein-Barr virus transcript in anaplastic large-cell lymphomas by mRNA in situ hybridization. Hum Pathol. 1997;28:1415-1419.","journal-title":"Hum Pathol"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF02986619","volume":"77","author":"Hirose, Y","year":"2003","unstructured":"Hirose Y, Masaki Y, Shimoyama K, et al. Epstein-Barr virus-associated anaplastic large cell variant of diffuse large B-cell-type non-Hodgkin's lymphoma with concurrent p53 protein expression. Int J Hematol. 2003;77:499-502.","journal-title":"Int J Hematol"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1073\/pnas.90.12.5455","volume":"90","author":"Szekely, W","year":"1993","unstructured":"Szekely W, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993;90:5455-5459.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1128\/JVI.70.7.4849-4853.1996","volume":"70","author":"Chen, W","year":"1996","unstructured":"Chen W, Cooper NR. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-3B activity. J Virol. 1996;70:4849-4853.","journal-title":"J Virol"},{"key":"E00022","first-page":"15","author":"Shibata, D","year":"1991","unstructured":"Shibata D, Weiss LM, Nathwani BN, et al. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood. 1991;77: 1527-1533.","journal-title":"Blood"},{"key":"E00023","first-page":"1673","author":"Hirose, Y","year":"1996","unstructured":"Hirose Y, Masaki Y, Shimizu S, et al. Association of Epstein-Barr virus with human immunodeficiency virus-negative T cell lymphomas in Japan, in situ hybridization, polymerase chain reaction and immunohistochemical studies. Leukemia. 1996;10:1673-1675.","journal-title":"Leukemia"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.1993.tb00093.x","author":"Khan, G","year":"1993","unstructured":"Khan G, Norton AJ, Slavin G. Epstein-Barr virus in angioimmuno-blastic T-cell lymphomas. Histopathology. 1993;22:145-149.","journal-title":"Histopathology"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1309\/VF28-E64G-1DND-LF94","volume":"113","author":"Menke","year":"2000","unstructured":"Menke DM, Griesser H, Moder KG, et al. Lymphomas in patients with connective tissue disease: comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol. 2000; 113:212-218.","journal-title":"Am J Clin Pathol"},{"key":"E00026","first-page":"1699","volume":"6","author":"Bartek, J","year":"1991","unstructured":"Bartek J, Bartkova J, Vojtesek B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991;6:1699-1703.","journal-title":"Oncogene"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/JVI.68.3.1309-1315.1994","volume":"68","author":"Edwards, RH","year":"1994","unstructured":"Edwards RH, Raab-Traub N. Alterations of p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas. J Virol. 1994;68:1309-1315.","journal-title":"J Virol"},{"key":"E00028","first-page":"845","volume":"143","author":"Cesarman, E","year":"1993","unstructured":"Cesarman E, Inghirami G, Chadburn A, et al. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol. 1993;143:845-856.","journal-title":"Am J Pathol"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1073\/pnas.90.12.5455","volume":"90","author":"Szekely, L","year":"1993","unstructured":"Szekely L, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A. 1993;90:5459-5459.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1128\/JVI.70.7.4849-4853.1996","volume":"70","author":"Chen, W","year":"1996","unstructured":"Chen W, Cooper NR. Epstein-Barr virus nuclear antigen-2 and latent membrane protein independently transactivate p53 through induction of NF-3B activity. J Virol. 1996;70:4849-4853.","journal-title":"J Virol"},{"key":"E00031","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","volume":"27","author":"Oyama","year":"2003","unstructured":"Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16-26.","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.03156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T07:47:06Z","timestamp":1587973626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.03156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["J24E4K6GKWBPQF29"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.03156","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}